SpineGuard and XinRong Medical Group sign an exclusive distribution agreement for PediGuard® in China
PARIS and SAN FRANCISCO, June [XX]th, 2017 – 18:00 CET – SpineGuard (FR0011464452 – ALSGD), an innovative company that develops and markets disposable medical devices designed to make spine surgery safer, announced today an exclusive distribution agreement with XinRong Medical Group for selling and marketing PediGuard® in China, Hong Kong and Macau.
The ChineseChina’s spine market has become the world’s second-largest market in spine after the USA and is expected to be worth over US$1 billion by 2019 , driven by an ageing population, increasing disease prevalence, improving treatment rate, and growing affordability. “We are thrilled by this agreement and I believe XinRong Medical Group has the right attributes to successfully introduce PediGuard in China where the number of spine fusions is growing rapidly creating a substantial need for a simple smart device consistently securing the placement of pedicle screws. Since its clearance by CFDA, numerous Chinese orthopedists and neurosurgeons expressed a strong interest for our DSG™ technology. We now very much look forward to seeing them adopt it in their spine surgery practice..,”, said Pierre Jérôme, CEO and co-founder of SpineGuard.
“XR Medical is delighted to have partner with SpineGuard, the inventor of PediGuard and DSG™ technology. PediGuard is one of its kind in the market, and XinRongR Medical is very excited to introduce one of most advanced surgical solutions globally to the China market. SpineGuard’s cutting-edge technology allows surgical staff and patients to significantly reduce exposure to surgical radiation in the operating room (OR) and help surgeons achieve more precise spinal implantation in real time. “Ease of Use, Economy, Accuracy, and Safety” is what we want to bring surgeons in China, through which we could realize our vision of putting patients first. ”, added Christine Zhang, XinRong Medical Group’s CEO.
Next financial press release: 2016 Half-year revenue: July 6, 2017
Founded in 2009 in France and the USA, by Pierre Jérôme and Stéphane Bette, SpineGuard’s mission is to make spine surgery safer by bringing real-time digital technology into the operating room. Its primary objective is to establish its proprietary DSG™ (Dynamic Surgical Guidance) technology as the global standard of surgical care, starting with safer screw placement in spine surgery and then in other surgeries. PediGuard®, the first device designed using DSG, was co-invented by Maurice Bourlion, Ph.D., Ciaran Bolger, M.D., Ph.D., and Alain Vanquaethem, Biomedical Engineer. It is the world’s first and only handheld device capable of alerting surgeons to potential pedicular or vertebral breaches. Over 50,000 surgical procedures have been performed worldwide with DSG™ enabled devices. Numerous studies published in peer-reviewed medical and scientific journals have demonstrated the multiple benefits that PediGuard® delivers to patients, surgical staff and hospitals. SpineGuard is expanding the scope of its DSG™ platform through strategic partnerships with innovative medical device companies and the development of smart instruments and implants. SpineGuard has offices in San Francisco and Paris. For further information, visit www.spineguard.com.